Cleared Special

K170614 - CareSens N Premier Blood Glucose Monitoring System, CareSens N Premier BT Blood Glucose Monitoring System

K170614 is an FDA 510(k) clearance for CareSens N Premier Blood Glucose Monito..., manufactured by I-Sens, Inc.. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 232-day FDA review.

K170614 · I-Sens, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2017
Decision
232d
Days
Class 2
Risk

K170614 is an FDA 510(k) clearance for the CareSens N Premier Blood Glucose Monitoring System, CareSens N Premier BT Blo.... Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by I-Sens, Inc. (Seoul, KR). The FDA issued a Cleared decision on October 19, 2017 after a review of 232 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all I-Sens, Inc. devices

FDA 510(k) Submission Details - K170614

510(k) Number K170614 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 2017
Decision Date October 19, 2017
Days to Decision 232 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
144d slower than avg
Panel avg: 88d · This submission: 232d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 505
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K170614.
NoCoding1 Plus Blood Glucose Monitoring System, VeraSens Blood Glucose Monitoring System
K171480 · I-Sens, Inc. · Dec 2017
StatStrip Xpress Blood Glucose Monitoring System
K170464 · Nova Biomedical Corporation · Nov 2017
PixoTest Blood Glucose Monitoring System
K163087 · Ixensor Company , Ltd. · Nov 2017
SD LipidoCare Professional System, SD LipidoCare Home System, SD LipidoCare BT Professional System, SD LipidoCare BT Home System
K160282 · Sd Biosensor · Oct 2017
GlucoDr.S Blood Glucose Monitoring System, GlucoDr.S BLE Blood Glucose Monitoring System, GlucoDr.S NFC Blood Glucose Monitoring System
K170241 · All Medicus Co., Ltd. · Oct 2017
Tyson Bio HT100 Blood Glucose Monitoring System, Tyson Bio HT100-B Blood Glucose Monitoring System
K170079 · Tyson Bioresearch, Inc. · Oct 2017